The size of the Bone Growth Stimulators Market in the Asia Pacific was worth USD 0.28 billion in 2021 and is estimated to be growing at a CAGR of 5.5% to reach USD 0.37 Billion by 2026 during the forecast period.
Y-O-Y growth in the number of injuries through road accidents every year, the growing necessity for non-invasive and minimum invasive treatments are primarily boosting the bone growth stimulators market growth in the Asia Pacific. On-going research activities, growing patient and physician obtainment, and favorable reimbursement policies provide decent support to the growth rate of the bone growth stimulators market in the Asia Pacific.
High costs and repeated product recalls are key factors expected to impact the bone growth stimulators market in APAC negatively. Lack of awareness regarding the bone growth and scarcity of expert professionals required for treating the patients may also obstruct the growth.
This research report on the APAC Bone Growth Stimulators Market has been segmented and sub-segmented into the following categories.
By Product:
By Application:
By End User:
By Country:
Regionally, The Asia-Pacific is accounted to grow with the highest CAGR rate during the forecast period. The growth is attributed to factors like the increasing number of road accidents and developing healthcare infrastructure among the APAC countries. The growing number of people suffering from spinal injuries, besides an increase in the rate of surgery.
The Chinese bone growth stimulators market is predicted to be one of the quickest growing markets in the APAC region, with a 6.1% CAGR. The government has taken several initiatives in advancing the healthcare systems by assuring 95% of the population who have some form of coverage. Moreover, healthcare in China is costly, and quality is below equivalence. An increase in the elder people population and a growing middle-class population escalates the APAC region's bone growth stimulators market.
The bone growth stimulators market in Japan is predicted to experience a CAGR of 9.8% in the region over the analysis period. The growth in Japan is due to an increasing number of injuries and trauma, increasing spinal and orthopedic procedures.
The Indian bone growth stimulators market is ready to augment to grow with a CAGR of 9.8% during the review period due to increasing funds and investments from government and other private organizations towards the healthcare domain, increasing research and development expenses, and rising massive number of medical equipment companies of this region which leads to the fast growth during the historical period.
Major Companies dominating the Asia Pacific Bone Growth Stimulators Market are DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Ossatec Benelux BV, Verve Consulting Inc., and IGEA S.p.A.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Bone Growth Stimulation Devices
5.1.2.1 External Bone Growth Stimulators
5.1.2.2 Implanted Bone Growth Stimulators
5.1.2.3 Ultrasonic Bone Growth Stimulators
5.1.3 Bone Morphogenetic Proteins
5.1.4 Platelet-rich Plasma
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Spinal Fusion Surgeries
5.2.3 Delayed Union & Nonunion Bone Fractures
5.2.4 Other Applications
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
5.3 End user
5.3.1 Introduction
5.3.2 Hospitals and Clinics
5.3.3 Home Care
5.3.4 Academic & Research Institutes
5.3.5 CROs
5.3.6 Y-o-Y Growth Analysis, By End user
5.3.7 Market Attractiveness Analysis, By End user
5.3.8 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 DJO LLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Orthofix International N.V
8.3 Zimmer Biomet Holdings Inc
8.4 Elizur, Bioventus LLC
8.5 Ossatec Benelux BV
8.6 Verve Consulting Inc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
